HB Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-6,265
Closed -$214K 763
2023
Q2
$214K Buy
+6,265
New +$197K ﹤0.01% 657

Other funds holding ARKG

HB Wealth Management's ARKG Position: Q3 2023 in Review

HB Wealth Management sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2023, closing a stake of 6,265 shares — an estimated $214K sold.

HB Wealth Management first reported a position in ARKG in Q2 2023 and held it in 1 quarter. The position peaked at $214K in Q2 2023. 286 funds tracked by Wall St. Rank hold ARKG as of Q3 2023.

  • HB Wealth Management reported no remaining ARK Genomic Revolution ETF position as of Q3 2023 after selling out during the quarter.
  • HB Wealth Management sold 6,265 ARK Genomic Revolution ETF shares in Q3 2023, an estimated $214K.
  • HB Wealth Management first reported a position in ARK Genomic Revolution ETF in Q2 2023 and held it in 1 quarter.
  • HB Wealth Management's ARK Genomic Revolution ETF position peaked at $214K in Q2 2023.
  • 286 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2023.

Based on HB Wealth Management's 13F filing for Q3 2023, filed 13 Oct 2023.